296 related articles for article (PubMed ID: 36661732)
21. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies.
Grisaru D; Almog B; Levine C; Metser U; Fishman A; Lerman H; Lessing JB; Even-Sapir E
Gynecol Oncol; 2004 Sep; 94(3):680-4. PubMed ID: 15350358
[TBL] [Abstract][Full Text] [Related]
22. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
23. Added Value of FDG PET/MRI in Gynecologic Oncology: A Pictorial Review.
Tarcha Z; Konstantinoff KS; Ince S; Fraum TJ; Sadowski EA; Bhosale PR; Derenoncourt PR; Zulfiqar M; Shetty AS; Ponisio MR; Mhlanga JC; Itani M
Radiographics; 2023 Aug; 43(8):e230006. PubMed ID: 37410624
[TBL] [Abstract][Full Text] [Related]
24. Potential applications of PET/MRI in non-oncologic conditions within the abdomen and pelvis.
Bartlett DJ; Takahashi H; Bach CR; Lunn B; Thorpe MP; Broski SM; Packard AT; Fletcher JG; Navin PJ
Abdom Radiol (NY); 2023 Dec; 48(12):3624-3633. PubMed ID: 37145312
[TBL] [Abstract][Full Text] [Related]
25. MRI and FDG-PET/CT imaging in gynecological malignancies: the radiation oncology perspective.
Fennell J; Scholber J; Grosu AL; Volegova-Neher N; Henne K; Langer M; Meyer PT; Gitsch G; Bartl N
Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):117-23. PubMed ID: 26957003
[TBL] [Abstract][Full Text] [Related]
26. Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.
Yu JQ; Doss M; Alpaugh RK
PET Clin; 2018 Apr; 13(2):249-268. PubMed ID: 29482753
[TBL] [Abstract][Full Text] [Related]
27. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET Assessment of Other Gynecologic Cancers.
Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous
Maclean J; Fersht N; Sullivan K; Kayani I; Bomanji J; Dickson J; O'Meara C; Short S
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):448-458. PubMed ID: 28433399
[TBL] [Abstract][Full Text] [Related]
30. Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) Combined with Positron Emission Tomography-Computed Tomography (PET-CT) and Video-Electroencephalography (VEEG) Have Excellent Diagnostic Value in Preoperative Localization of Epileptic Foci in Children with Epilepsy.
Wang GB; Long W; Li XD; Xu GY; Lu JX
Med Sci Monit; 2017 Jan; 23():1-10. PubMed ID: 28040805
[TBL] [Abstract][Full Text] [Related]
31. Novel imaging modalities in gynecologic cancer.
Brooks RA; Powell MA
Curr Oncol Rep; 2009 Nov; 11(6):466-72. PubMed ID: 19840524
[TBL] [Abstract][Full Text] [Related]
32. Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT.
Grueneisen J; Schaarschmidt BM; Heubner M; Suntharalingam S; Milk I; Kinner S; Heubner A; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
Eur J Radiol; 2015 Nov; 84(11):2097-102. PubMed ID: 26321491
[TBL] [Abstract][Full Text] [Related]
33. Computed tomography, magnetic resonance imaging and FDG positron emission tomography in the management of vulvar malignancies.
Lin G; Chen CY; Liu FY; Yang LY; Huang HJ; Huang YT; Jung SM; Chou HH; Lai CH; Ng KK
Eur Radiol; 2015 May; 25(5):1267-78. PubMed ID: 25477274
[TBL] [Abstract][Full Text] [Related]
34. PET/MRI: Emerging Clinical Applications in Oncology.
Fraum TJ; Fowler KJ; McConathy J
Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis.
Li X; Wang L; Guo P; Sun Q; Zhang Y; Chen C; Zhang Y
Ann Nucl Med; 2023 Oct; 37(10):541-550. PubMed ID: 37422857
[TBL] [Abstract][Full Text] [Related]
36. Discrepancies between positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography in a cohort of oncological patients.
Oh G; O'Mahoney E; Jeavons S; Law P; Ngai S; McGill G; Yu C; Miles KA
J Med Imaging Radiat Oncol; 2020 Apr; 64(2):204-210. PubMed ID: 32037655
[TBL] [Abstract][Full Text] [Related]
37. Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.
Behzadi AH; Raza SI; Carrino JA; Kosmas C; Gholamrezanezhad A; Basques K; Matcuk GR; Patel J; Jadvar H
PET Clin; 2018 Oct; 13(4):623-634. PubMed ID: 30219192
[TBL] [Abstract][Full Text] [Related]
38. A Role of PET Agents Beyond FDG in Gynecology.
Ponisio MR; Dehdashti F
Semin Nucl Med; 2019 Nov; 49(6):501-511. PubMed ID: 31630734
[TBL] [Abstract][Full Text] [Related]
39. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
[TBL] [Abstract][Full Text] [Related]
40. What's New in Imaging for Gynecologic Cancer?
Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
